DOI: 10.1016/j.tips.2008.10.005. Neurobiology and treatment of Parkinson's disease

Neurobiology and treatment of Parkinson's disease

10.1016/j.tips.2008.10.005

Crossref journal-article

Elsevier BV

Trends in Pharmacological Sciences (78)

Bibliography

Schapira, A. H. V. (2009). Neurobiology and treatment of Parkinsonâs disease. Trends in Pharmacological Sciences, 30(1), 41â47.

Authors 1

Anthony H.V. Schapira (first)

References 83 Referenced 196

10.1016/S1474-4422(06)70373-8 / Lancet Neurol. / Non-motor symptoms of Parkinson's disease: diagnosis and management by Chaudhuri (2006)
10.1002/ana.10487 / Ann. Neurol. / Genetic and environmental factors in the cause of Parkinson's disease by Warner (2003)
10.1126/science.276.5321.2045 / Science / Mutation in the alpha-synuclein gene identified in families with Parkinson's disease by Polymeropoulos (1997)
10.1038/ng0298-106 / Nat. Genet. / Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease by Kruger (1998)
10.1126/science.1090278 / Science / alpha-Synuclein locus triplication causes Parkinson's disease by Singleton (2003)
10.1002/ana.10846 / Ann. Neurol. / Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications by Farrer (2004)
10.1002/ana.10795 / Ann. Neurol. / The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia by Zarranz (2004)
10.1038/33416 / Nature / Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism by Kitada (1998)
10.1002/ana.410440612 / Ann. Neurol. / Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals by Hattori (1998)
10.1093/hmg/8.4.567 / Hum. Mol. Genet. / A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease by Abbas (1999)
10.1038/77060 / Nat. Genet. / Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase by Shimura (2000)
10.1073/pnas.0405313101 / Proc. Natl. Acad. Sci. U. S. A. / Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease by Lo Bianco (2004)
10.1126/science.1096284 / Science / Hereditary early-onset Parkinson's disease caused by mutations in PINK1 by Valente (2004)
10.1038/sj.onc.1204608 / Oncogene / Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway by Unoki (2001)
10.1002/ana.20256 / Ann. Neurol. / PINK1 mutations are associated with sporadic early-onset parkinsonism by Valente (2004)
10.1002/ana.20251 / Ann. Neurol. / Novel PINK1 mutations in early-onset parkinsonism by Hatano (2004)
10.1002/ana.20247 / Ann. Neurol. / Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism by Rohe (2004)
10.1001/archneur.63.9.1225 / Arch. Neurol. / The importance of LRRK2 mutations in Parkinson disease by Schapira (2006)
10.1002/ana.20636 / Ann. Neurol. / G2019S LRRK2 mutation in French and North African families with Parkinson's disease by Lesage (2005)
10.1016/S1474-4422(08)70117-0 / Lancet Neurol. / Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study by Healy (2008)
10.1017/S0317167100036635 / Can. J. Neurol. Sci. / Early onset Parkinson's disease in Saskatchewan–environmental considerations for etiology by Rajput (1986)
10.1159/000110148 / Neuroepidemiology / Neurological disorders and services in Saskatchewan–a report based on provincial health care records by Rajput (1988)
10.1212/WNL.66.10_suppl_4.S10 / Neurology / Etiology of Parkinson's disease by Schapira (2006)
10.1212/WNL.42.7.1328 / Neurology / Parkinson's disease and exposure to agricultural work and pesticide chemicals by Semchuk (1992)
10.1016/S0140-6736(89)92366-0 / Lancet / Mitochondrial complex I deficiency in Parkinson's disease by Schapira (1989)
10.1111/j.1471-4159.1990.tb02325.x / J. Neurochem. / Mitochondrial complex I deficiency in Parkinson's disease by Schapira (1990)
10.1002/ana.410360612 / Ann. Neurol. / Complex I, iron, and ferritin in Parkinson's disease substantia nigra by Mann (1994)
10.1111/j.1471-4159.1990.tb05809.x / J. Neurochem. / Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease by Schapira (1990)
10.1111/j.1749-6632.1996.tb39064.x / Ann. N. Y. Acad. Sci. / Oxidative stress and Parkinson's disease by Owen (1996)
10.1002/mds.21013 / Mov. Disord. / Ubiquitin-proteasome system and Parkinson's disease by Olanow (2006)
10.1016/j.expneurol.2003.08.004 / Exp. Neurol. / Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter by Hartmann (2003)
10.1016/S0197-4580(02)00065-9 / Neurobiol. Aging / Staging of brain pathology related to sporadic Parkinson's disease by Braak (2003)
10.1002/ana.20789 / Ann. Neurol. / Timing of treatment initiation in Parkinson's disease: a need for reappraisal? by Schapira (2006)
10.1136/bmj.38184.606169.AE / BMJ / Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients by Ives (2004)
10.1001/archneur.59.12.1937 / Arch. Neurol. / A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study by Parkinson Disease Study Group (2002)
10.1038/nrd1803 / Nat. Rev. Drug Discov / Rasagiline by Schapira (2005)
10.1016/S0140-6736(05)71083-7 / Lancet / Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial by Rascol (2005)
10.1212/WNL.41.2_Part_1.202 / Neurology / Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease by Kostic (1991)
10.1016/S1471-1931(00)00030-6 / Trends Neurosci. / Continuous dopamine-receptor stimulation in early Parkinson's disease by Olanow (2000)
10.1056/NEJM200005183422004 / N. Engl. J. Med. / A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group by Rascol (2000)
10.1001/jama.284.15.1931 / J. Am. Med. Assoc. / Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial (2000)
10.1002/mds.21741 / Mov. Disord. / Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole by Giladi (2007)
10.1002/mds.20464 / Mov. Disord. / Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 by Goetz (2005)
10.1212/01.wnl.0000215250.82576.87 / Neurology / Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology by Pahwa (2006)
{'issue': 'Suppl 4', 'key': '10.1016/j.tips.2008.10.005_bib45', 'first-page': 'S1', 'article-title': "Management of Parkinson's disease: an evidence-based review", 'volume': '17', 'author': 'Parkinson Study Group', 'year': '2002', 'journal-title': 'Mov. Disord.'} / Mov. Disord. / Management of Parkinson's disease: an evidence-based review by Parkinson Study Group (2002)
Sanjeev Bhattacharyya, S. et al. Drug-induced valvular heart disease. Lancet (in press)
10.1097/01.WNF.0000232277.68501.08 / Clin. Neuropharmacol. / End-of-dose wearing off in Parkinson disease: a 9-question survey assessment by Stacy (2006)
10.1016/j.neuropharm.2003.10.015 / Neuropharmacology / Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells by Korlipara (2004)
10.1002/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H / Mov. Disord. / Apomorphine: an underutilized therapy for Parkinson's disease by Poewe (2000)
10.1034/j.1600-0404.2001.00153.x / Acta Neurol. Scand. / Duodenal levodopa infusion in Parkinson's disease–long-term experience by Nilsson (2001)
10.1002/mds.21586 / Mov. Disord. / Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients by Martinez-Martin (2007)
10.1038/nrd2087 / Nat. Rev. Drug Discov. / Novel pharmacological targets for the treatment of Parkinson's disease by Schapira (2006)
10.1002/mds.21679 / Mov. Disord. / Future directions in the treatment of Parkinson's disease by Schapira (2007)
10.1001/archneur.64.8.1083 / Arch. Neurol. / Treatment options in the modern management of Parkinson disease by Schapira (2007)
10.1136/bmj.318.7179.311 / BMJ / Science, medicine and the future: Parkinson's disease by Schapira (1999)
10.1016/S1474-4422(04)00769-0 / Lancet Neurol. / Disease modification in Parkinson's disease by Schapira (2004)
10.1056/NEJM199301213280305 / N. Engl. J. Med. / Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease by The Parkinson Study Group (1993)
10.1212/01.wnl.0000204007.46190.54 / Neurology / Selegiline slows the progression of the symptoms of Parkinson disease by Palhagen (2006)
10.1001/archneur.61.4.561 / Arch. Neurol. / A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease by The Parkinson Study Group (2004)
10.1001/jama.287.13.1653 / J. Am. Med. Assoc. / Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression by The Parkinson Study Group (2002)
10.1002/ana.10609 / Ann. Neurol. / Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study by Whone (2003)
10.1001/jama.291.3.358 / J. Am. Med. Assoc. / Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions by Schapira (2004)
10.1056/NEJMoa033447 / N. Engl. J. Med. / Levodopa and the progression of Parkinson's disease by Fahn (2004)
10.1001/archneur.59.10.1541 / Arch. Neurol. / Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline by Shults (2002)
10.1212/01.wnl.0000250355.28474.8e / Neurology / A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease by The Parkinson Study Group (2007)
10.1212/01.wnl.0000201252.57661.e1 / Neurology / A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease by The Parkinson Study Group (2006)
10.1212/01.wnl.0000238518.34389.12 / Neurology / Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial by Bender (2006)
10.1016/S1474-4422(06)70602-0 / Lancet Neurol. / TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial by Olanow (2006)
10.1038/nature05865 / Nature / ’Rejuvenation’ protects neurons in mouse models of Parkinson's disease by Chan (2007)
10.1016/S1474-4422(07)70246-6 / Lancet Neurol. / Calcium, ageing, and neuronal vulnerability in Parkinson's disease by Surmeier (2007)
10.1016/S0006-8993(96)00917-1 / Brain Res. / 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level by Kupsch (1996)
10.1046/j.1471-4159.1999.0730214.x / J. Neurochem. / Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse by Jenkins (1999)
10.1212/01.wnl.0000303818.38960.44 / Neurology / Use of antihypertensives and the risk of Parkinson disease by Becker (2008)
10.1056/NEJM200103083441002 / N. Engl. J. Med. / Transplantation of embryonic dopamine neurons for severe Parkinson's disease by Freed (2001)
10.1002/ana.10720 / Ann. Neurol. / A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease by Olanow (2003)
10.1038/nm1746 / Nat. Med. / Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation by Li (2008)
10.1038/nm1747 / Nat. Med. / Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease by Kordower (2008)
10.1016/S0006-8993(98)00790-2 / Brain Res. / Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins by Seaton (1998)
10.1093/brain/awf234 / Brain / Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys by Grondin (2002)
10.1126/science.290.5492.767 / Science / Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease by Kordower (2000)
10.1212/WNL.60.1.69 / Neurology / Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD by Nutt (2003)
10.1016/S1474-4422(08)70065-6 / Lancet Neurol. / Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial by Marks (2008)
10.1016/S1474-4422(07)70327-7 / Lancet Neurol. / Mitochondria in the aetiology and pathogenesis of Parkinson's disease by Schapira (2008)

Dates

Type	When
Created	16 years, 9 months ago (Nov. 29, 2008, 11:08 p.m.)
Deposited	6 years, 8 months ago (Dec. 23, 2018, 4:26 p.m.)
Indexed	1 month ago (July 30, 2025, 11:23 a.m.)
Issued	16 years, 8 months ago (Jan. 1, 2009)
Published	16 years, 8 months ago (Jan. 1, 2009)
Published Print	16 years, 8 months ago (Jan. 1, 2009)

Funders 0

None

BibTeX

@article{Schapira_2009, title={Neurobiology and treatment of Parkinson’s disease}, volume={30}, ISSN={0165-6147}, url={http://dx.doi.org/10.1016/j.tips.2008.10.005}, DOI={10.1016/j.tips.2008.10.005}, number={1}, journal={Trends in Pharmacological Sciences}, publisher={Elsevier BV}, author={Schapira, Anthony H.V.}, year={2009}, month=jan, pages={41–47} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        7,
        30
      ]
    ],
    "date-time": "2025-07-30T15:23:50Z",
    "timestamp": 1753889030525
  },
  "reference-count": 83,
  "publisher": "Elsevier BV",
  "issue": "1",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2009,
            1,
            1
          ]
        ],
        "date-time": "2009-01-01T00:00:00Z",
        "timestamp": 1230768000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        1
      ]
    ]
  },
  "DOI": "10.1016/j.tips.2008.10.005",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2008,
        11,
        30
      ]
    ],
    "date-time": "2008-11-30T04:08:12Z",
    "timestamp": 1228018092000
  },
  "page": "41-47",
  "source": "Crossref",
  "is-referenced-by-count": 196,
  "title": "Neurobiology and treatment of Parkinson's disease",
  "prefix": "10.1016",
  "volume": "30",
  "author": [
    {
      "given": "Anthony H.V.",
      "family": "Schapira",
      "sequence": "first",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.tips.2008.10.005_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "DOI": "10.1016/S1474-4422(06)70373-8",
      "article-title": "Non-motor symptoms of Parkinson's disease: diagnosis and management",
      "volume": "5",
      "author": "Chaudhuri",
      "year": "2006",
      "journal-title": "Lancet Neurol."
    },
    {
      "issue": "Suppl 3",
      "key": "10.1016/j.tips.2008.10.005_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "S16",
      "DOI": "10.1002/ana.10487",
      "article-title": "Genetic and environmental factors in the cause of Parkinson's disease",
      "volume": "53",
      "author": "Warner",
      "year": "2003",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "2045",
      "DOI": "10.1126/science.276.5321.2045",
      "article-title": "Mutation in the alpha-synuclein gene identified in families with Parkinson's disease",
      "volume": "276",
      "author": "Polymeropoulos",
      "year": "1997",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "106",
      "DOI": "10.1038/ng0298-106",
      "article-title": "Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease",
      "volume": "18",
      "author": "Kruger",
      "year": "1998",
      "journal-title": "Nat. Genet."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "841",
      "DOI": "10.1126/science.1090278",
      "article-title": "alpha-Synuclein locus triplication causes Parkinson's disease",
      "volume": "302",
      "author": "Singleton",
      "year": "2003",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "174",
      "DOI": "10.1002/ana.10846",
      "article-title": "Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications",
      "volume": "55",
      "author": "Farrer",
      "year": "2004",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "164",
      "DOI": "10.1002/ana.10795",
      "article-title": "The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia",
      "volume": "55",
      "author": "Zarranz",
      "year": "2004",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "605",
      "DOI": "10.1038/33416",
      "article-title": "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism",
      "volume": "392",
      "author": "Kitada",
      "year": "1998",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "935",
      "DOI": "10.1002/ana.410440612",
      "article-title": "Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals",
      "volume": "44",
      "author": "Hattori",
      "year": "1998",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "567",
      "DOI": "10.1093/hmg/8.4.567",
      "article-title": "A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease",
      "volume": "8",
      "author": "Abbas",
      "year": "1999",
      "journal-title": "Hum. Mol. Genet."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "302",
      "DOI": "10.1038/77060",
      "article-title": "Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase",
      "volume": "25",
      "author": "Shimura",
      "year": "2000",
      "journal-title": "Nat. Genet."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "17510",
      "DOI": "10.1073/pnas.0405313101",
      "article-title": "Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease",
      "volume": "101",
      "author": "Lo Bianco",
      "year": "2004",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "1158",
      "DOI": "10.1126/science.1096284",
      "article-title": "Hereditary early-onset Parkinson's disease caused by mutations in PINK1",
      "volume": "304",
      "author": "Valente",
      "year": "2004",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "4457",
      "DOI": "10.1038/sj.onc.1204608",
      "article-title": "Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway",
      "volume": "20",
      "author": "Unoki",
      "year": "2001",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "336",
      "DOI": "10.1002/ana.20256",
      "article-title": "PINK1 mutations are associated with sporadic early-onset parkinsonism",
      "volume": "56",
      "author": "Valente",
      "year": "2004",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "424",
      "DOI": "10.1002/ana.20251",
      "article-title": "Novel PINK1 mutations in early-onset parkinsonism",
      "volume": "56",
      "author": "Hatano",
      "year": "2004",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "427",
      "DOI": "10.1002/ana.20247",
      "article-title": "Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism",
      "volume": "56",
      "author": "Rohe",
      "year": "2004",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "1225",
      "DOI": "10.1001/archneur.63.9.1225",
      "article-title": "The importance of LRRK2 mutations in Parkinson disease",
      "volume": "63",
      "author": "Schapira",
      "year": "2006",
      "journal-title": "Arch. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "784",
      "DOI": "10.1002/ana.20636",
      "article-title": "G2019S LRRK2 mutation in French and North African families with Parkinson's disease",
      "volume": "58",
      "author": "Lesage",
      "year": "2005",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "583",
      "DOI": "10.1016/S1474-4422(08)70117-0",
      "article-title": "Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study",
      "volume": "7",
      "author": "Healy",
      "year": "2008",
      "journal-title": "Lancet Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "312",
      "DOI": "10.1017/S0317167100036635",
      "article-title": "Early onset Parkinson's disease in Saskatchewan\u2013environmental considerations for etiology",
      "volume": "13",
      "author": "Rajput",
      "year": "1986",
      "journal-title": "Can. J. Neurol. Sci."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "DOI": "10.1159/000110148",
      "article-title": "Neurological disorders and services in Saskatchewan\u2013a report based on provincial health care records",
      "volume": "7",
      "author": "Rajput",
      "year": "1988",
      "journal-title": "Neuroepidemiology"
    },
    {
      "issue": "10 Suppl. 4",
      "key": "10.1016/j.tips.2008.10.005_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "S10",
      "DOI": "10.1212/WNL.66.10_suppl_4.S10",
      "article-title": "Etiology of Parkinson's disease",
      "volume": "66",
      "author": "Schapira",
      "year": "2006",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "1328",
      "DOI": "10.1212/WNL.42.7.1328",
      "article-title": "Parkinson's disease and exposure to agricultural work and pesticide chemicals",
      "volume": "42",
      "author": "Semchuk",
      "year": "1992",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "1269",
      "DOI": "10.1016/S0140-6736(89)92366-0",
      "article-title": "Mitochondrial complex I deficiency in Parkinson's disease",
      "volume": "1",
      "author": "Schapira",
      "year": "1989",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "823",
      "DOI": "10.1111/j.1471-4159.1990.tb02325.x",
      "article-title": "Mitochondrial complex I deficiency in Parkinson's disease",
      "volume": "54",
      "author": "Schapira",
      "year": "1990",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "876",
      "DOI": "10.1002/ana.410360612",
      "article-title": "Complex I, iron, and ferritin in Parkinson's disease substantia nigra",
      "volume": "36",
      "author": "Mann",
      "year": "1994",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "2142",
      "DOI": "10.1111/j.1471-4159.1990.tb05809.x",
      "article-title": "Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease",
      "volume": "55",
      "author": "Schapira",
      "year": "1990",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "217",
      "DOI": "10.1111/j.1749-6632.1996.tb39064.x",
      "article-title": "Oxidative stress and Parkinson's disease",
      "volume": "786",
      "author": "Owen",
      "year": "1996",
      "journal-title": "Ann. N. Y. Acad. Sci."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "1806",
      "DOI": "10.1002/mds.21013",
      "article-title": "Ubiquitin-proteasome system and Parkinson's disease",
      "volume": "21",
      "author": "Olanow",
      "year": "2006",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "DOI": "10.1016/j.expneurol.2003.08.004",
      "article-title": "Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter",
      "volume": "184",
      "author": "Hartmann",
      "year": "2003",
      "journal-title": "Exp. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "DOI": "10.1016/S0197-4580(02)00065-9",
      "article-title": "Staging of brain pathology related to sporadic Parkinson's disease",
      "volume": "24",
      "author": "Braak",
      "year": "2003",
      "journal-title": "Neurobiol. Aging"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "DOI": "10.1002/ana.20789",
      "article-title": "Timing of treatment initiation in Parkinson's disease: a need for reappraisal?",
      "volume": "59",
      "author": "Schapira",
      "year": "2006",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "DOI": "10.1136/bmj.38184.606169.AE",
      "article-title": "Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients",
      "volume": "329",
      "author": "Ives",
      "year": "2004",
      "journal-title": "BMJ"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "1937",
      "DOI": "10.1001/archneur.59.12.1937",
      "article-title": "A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study",
      "volume": "59",
      "author": "Parkinson Disease Study Group",
      "year": "2002",
      "journal-title": "Arch. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "625",
      "DOI": "10.1038/nrd1803",
      "article-title": "Rasagiline",
      "volume": "4",
      "author": "Schapira",
      "year": "2005",
      "journal-title": "Nat. Rev. Drug Discov"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "947",
      "DOI": "10.1016/S0140-6736(05)71083-7",
      "article-title": "Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial",
      "volume": "365",
      "author": "Rascol",
      "year": "2005",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "202",
      "DOI": "10.1212/WNL.41.2_Part_1.202",
      "article-title": "Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease",
      "volume": "41",
      "author": "Kostic",
      "year": "1991",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "S117",
      "DOI": "10.1016/S1471-1931(00)00030-6",
      "article-title": "Continuous dopamine-receptor stimulation in early Parkinson's disease",
      "volume": "23",
      "author": "Olanow",
      "year": "2000",
      "journal-title": "Trends Neurosci."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "1484",
      "DOI": "10.1056/NEJM200005183422004",
      "article-title": "A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group",
      "volume": "342",
      "author": "Rascol",
      "year": "2000",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "1931",
      "DOI": "10.1001/jama.284.15.1931",
      "article-title": "Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial",
      "volume": "284",
      "year": "2000",
      "journal-title": "J. Am. Med. Assoc."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "2398",
      "DOI": "10.1002/mds.21741",
      "article-title": "Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole",
      "volume": "22",
      "author": "Giladi",
      "year": "2007",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "DOI": "10.1002/mds.20464",
      "article-title": "Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004",
      "volume": "20",
      "author": "Goetz",
      "year": "2005",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "983",
      "DOI": "10.1212/01.wnl.0000215250.82576.87",
      "article-title": "Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology",
      "volume": "66",
      "author": "Pahwa",
      "year": "2006",
      "journal-title": "Neurology"
    },
    {
      "issue": "Suppl 4",
      "key": "10.1016/j.tips.2008.10.005_bib45",
      "first-page": "S1",
      "article-title": "Management of Parkinson's disease: an evidence-based review",
      "volume": "17",
      "author": "Parkinson Study Group",
      "year": "2002",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib46",
      "unstructured": "Sanjeev Bhattacharyya, S. et al. Drug-induced valvular heart disease. Lancet (in press)"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "312",
      "DOI": "10.1097/01.WNF.0000232277.68501.08",
      "article-title": "End-of-dose wearing off in Parkinson disease: a 9-question survey assessment",
      "volume": "29",
      "author": "Stacy",
      "year": "2006",
      "journal-title": "Clin. Neuropharmacol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib48",
      "doi-asserted-by": "crossref",
      "first-page": "562",
      "DOI": "10.1016/j.neuropharm.2003.10.015",
      "article-title": "Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells",
      "volume": "46",
      "author": "Korlipara",
      "year": "2004",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib49",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "DOI": "10.1002/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H",
      "article-title": "Apomorphine: an underutilized therapy for Parkinson's disease",
      "volume": "15",
      "author": "Poewe",
      "year": "2000",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib50",
      "doi-asserted-by": "crossref",
      "first-page": "343",
      "DOI": "10.1034/j.1600-0404.2001.00153.x",
      "article-title": "Duodenal levodopa infusion in Parkinson's disease\u2013long-term experience",
      "volume": "104",
      "author": "Nilsson",
      "year": "2001",
      "journal-title": "Acta Neurol. Scand."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib51",
      "doi-asserted-by": "crossref",
      "first-page": "1623",
      "DOI": "10.1002/mds.21586",
      "article-title": "Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients",
      "volume": "22",
      "author": "Martinez-Martin",
      "year": "2007",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib52",
      "doi-asserted-by": "crossref",
      "first-page": "845",
      "DOI": "10.1038/nrd2087",
      "article-title": "Novel pharmacological targets for the treatment of Parkinson's disease",
      "volume": "5",
      "author": "Schapira",
      "year": "2006",
      "journal-title": "Nat. Rev. Drug Discov."
    },
    {
      "issue": "Suppl 17",
      "key": "10.1016/j.tips.2008.10.005_bib53",
      "doi-asserted-by": "crossref",
      "first-page": "S385",
      "DOI": "10.1002/mds.21679",
      "article-title": "Future directions in the treatment of Parkinson's disease",
      "volume": "22",
      "author": "Schapira",
      "year": "2007",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib54",
      "doi-asserted-by": "crossref",
      "first-page": "1083",
      "DOI": "10.1001/archneur.64.8.1083",
      "article-title": "Treatment options in the modern management of Parkinson disease",
      "volume": "64",
      "author": "Schapira",
      "year": "2007",
      "journal-title": "Arch. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib55",
      "doi-asserted-by": "crossref",
      "first-page": "311",
      "DOI": "10.1136/bmj.318.7179.311",
      "article-title": "Science, medicine and the future: Parkinson's disease",
      "volume": "318",
      "author": "Schapira",
      "year": "1999",
      "journal-title": "BMJ"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib56",
      "doi-asserted-by": "crossref",
      "first-page": "362",
      "DOI": "10.1016/S1474-4422(04)00769-0",
      "article-title": "Disease modification in Parkinson's disease",
      "volume": "3",
      "author": "Schapira",
      "year": "2004",
      "journal-title": "Lancet Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib57",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "DOI": "10.1056/NEJM199301213280305",
      "article-title": "Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease",
      "volume": "328",
      "author": "The Parkinson Study Group",
      "year": "1993",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib58",
      "doi-asserted-by": "crossref",
      "first-page": "1200",
      "DOI": "10.1212/01.wnl.0000204007.46190.54",
      "article-title": "Selegiline slows the progression of the symptoms of Parkinson disease",
      "volume": "66",
      "author": "Palhagen",
      "year": "2006",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib59",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "DOI": "10.1001/archneur.61.4.561",
      "article-title": "A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease",
      "volume": "61",
      "author": "The Parkinson Study Group",
      "year": "2004",
      "journal-title": "Arch. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib60",
      "doi-asserted-by": "crossref",
      "first-page": "1653",
      "DOI": "10.1001/jama.287.13.1653",
      "article-title": "Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression",
      "volume": "287",
      "author": "The Parkinson Study Group",
      "year": "2002",
      "journal-title": "J. Am. Med. Assoc."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib61",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "DOI": "10.1002/ana.10609",
      "article-title": "Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study",
      "volume": "54",
      "author": "Whone",
      "year": "2003",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib62",
      "doi-asserted-by": "crossref",
      "first-page": "358",
      "DOI": "10.1001/jama.291.3.358",
      "article-title": "Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions",
      "volume": "291",
      "author": "Schapira",
      "year": "2004",
      "journal-title": "J. Am. Med. Assoc."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib63",
      "doi-asserted-by": "crossref",
      "first-page": "2498",
      "DOI": "10.1056/NEJMoa033447",
      "article-title": "Levodopa and the progression of Parkinson's disease",
      "volume": "351",
      "author": "Fahn",
      "year": "2004",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib64",
      "doi-asserted-by": "crossref",
      "first-page": "1541",
      "DOI": "10.1001/archneur.59.10.1541",
      "article-title": "Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline",
      "volume": "59",
      "author": "Shults",
      "year": "2002",
      "journal-title": "Arch. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib65",
      "doi-asserted-by": "crossref",
      "first-page": "20",
      "DOI": "10.1212/01.wnl.0000250355.28474.8e",
      "article-title": "A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease",
      "volume": "68",
      "author": "The Parkinson Study Group",
      "year": "2007",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib66",
      "doi-asserted-by": "crossref",
      "first-page": "664",
      "DOI": "10.1212/01.wnl.0000201252.57661.e1",
      "article-title": "A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease",
      "volume": "66",
      "author": "The Parkinson Study Group",
      "year": "2006",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib67",
      "doi-asserted-by": "crossref",
      "first-page": "1262",
      "DOI": "10.1212/01.wnl.0000238518.34389.12",
      "article-title": "Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial",
      "volume": "67",
      "author": "Bender",
      "year": "2006",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib68",
      "doi-asserted-by": "crossref",
      "first-page": "1013",
      "DOI": "10.1016/S1474-4422(06)70602-0",
      "article-title": "TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial",
      "volume": "5",
      "author": "Olanow",
      "year": "2006",
      "journal-title": "Lancet Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib69",
      "doi-asserted-by": "crossref",
      "first-page": "1081",
      "DOI": "10.1038/nature05865",
      "article-title": "\u2019Rejuvenation\u2019 protects neurons in mouse models of Parkinson's disease",
      "volume": "447",
      "author": "Chan",
      "year": "2007",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib70",
      "doi-asserted-by": "crossref",
      "first-page": "933",
      "DOI": "10.1016/S1474-4422(07)70246-6",
      "article-title": "Calcium, ageing, and neuronal vulnerability in Parkinson's disease",
      "volume": "6",
      "author": "Surmeier",
      "year": "2007",
      "journal-title": "Lancet Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib71",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "DOI": "10.1016/S0006-8993(96)00917-1",
      "article-title": "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level",
      "volume": "741",
      "author": "Kupsch",
      "year": "1996",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib72",
      "doi-asserted-by": "crossref",
      "first-page": "214",
      "DOI": "10.1046/j.1471-4159.1999.0730214.x",
      "article-title": "Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse",
      "volume": "73",
      "author": "Jenkins",
      "year": "1999",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib73",
      "doi-asserted-by": "crossref",
      "first-page": "1438",
      "DOI": "10.1212/01.wnl.0000303818.38960.44",
      "article-title": "Use of antihypertensives and the risk of Parkinson disease",
      "volume": "70",
      "author": "Becker",
      "year": "2008",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib74",
      "doi-asserted-by": "crossref",
      "first-page": "710",
      "DOI": "10.1056/NEJM200103083441002",
      "article-title": "Transplantation of embryonic dopamine neurons for severe Parkinson's disease",
      "volume": "344",
      "author": "Freed",
      "year": "2001",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib75",
      "doi-asserted-by": "crossref",
      "first-page": "403",
      "DOI": "10.1002/ana.10720",
      "article-title": "A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease",
      "volume": "54",
      "author": "Olanow",
      "year": "2003",
      "journal-title": "Ann. Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib76",
      "doi-asserted-by": "crossref",
      "first-page": "501",
      "DOI": "10.1038/nm1746",
      "article-title": "Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation",
      "volume": "14",
      "author": "Li",
      "year": "2008",
      "journal-title": "Nat. Med."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib77",
      "doi-asserted-by": "crossref",
      "first-page": "504",
      "DOI": "10.1038/nm1747",
      "article-title": "Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease",
      "volume": "14",
      "author": "Kordower",
      "year": "2008",
      "journal-title": "Nat. Med."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib78",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "DOI": "10.1016/S0006-8993(98)00790-2",
      "article-title": "Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins",
      "volume": "809",
      "author": "Seaton",
      "year": "1998",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib79",
      "doi-asserted-by": "crossref",
      "first-page": "2191",
      "DOI": "10.1093/brain/awf234",
      "article-title": "Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys",
      "volume": "125",
      "author": "Grondin",
      "year": "2002",
      "journal-title": "Brain"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib80",
      "doi-asserted-by": "crossref",
      "first-page": "767",
      "DOI": "10.1126/science.290.5492.767",
      "article-title": "Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease",
      "volume": "290",
      "author": "Kordower",
      "year": "2000",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib81",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "DOI": "10.1212/WNL.60.1.69",
      "article-title": "Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD",
      "volume": "60",
      "author": "Nutt",
      "year": "2003",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib82",
      "doi-asserted-by": "crossref",
      "first-page": "400",
      "DOI": "10.1016/S1474-4422(08)70065-6",
      "article-title": "Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial",
      "volume": "7",
      "author": "Marks",
      "year": "2008",
      "journal-title": "Lancet Neurol."
    },
    {
      "key": "10.1016/j.tips.2008.10.005_bib83",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "DOI": "10.1016/S1474-4422(07)70327-7",
      "article-title": "Mitochondria in the aetiology and pathogenesis of Parkinson's disease",
      "volume": "7",
      "author": "Schapira",
      "year": "2008",
      "journal-title": "Lancet Neurol."
    }
  ],
  "container-title": "Trends in Pharmacological Sciences",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0165614708002411?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0165614708002411?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2018,
        12,
        23
      ]
    ],
    "date-time": "2018-12-23T21:26:42Z",
    "timestamp": 1545600402000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0165614708002411"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2009,
        1
      ]
    ]
  },
  "references-count": 83,
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2009,
          1
        ]
      ]
    }
  },
  "alternative-id": [
    "S0165614708002411"
  ],
  "URL": "http://dx.doi.org/10.1016/j.tips.2008.10.005",
  "relation": {},
  "ISSN": [
    "0165-6147"
  ],
  "subject": [],
  "container-title-short": "Trends in Pharmacological Sciences",
  "published": {
    "date-parts": [
      [
        2009,
        1
      ]
    ]
  }
}